Annual FCF
-$18.14 M
+$20.79 M+53.40%
May 26, 2024
Summary
- As of February 7, 2025, LFCR annual free cash flow is -$18.14 million, with the most recent change of +$20.79 million (+53.40%) on May 26, 2024.
- During the last 3 years, LFCR annual FCF has fallen by -$9.39 million (-107.24%).
- LFCR annual FCF is now -207.90% below its all-time high of $16.81 million, reached on May 1, 2012.
Performance
LFCR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$8.58 M
-$4.54 M-112.64%
November 24, 2024
Summary
- As of February 7, 2025, LFCR quarterly free cash flow is -$8.58 million, with the most recent change of -$4.54 million (-112.64%) on November 24, 2024.
- Over the past year, LFCR quarterly FCF has dropped by -$795.00 thousand (-10.21%).
- LFCR quarterly FCF is now -162.13% below its all-time high of $13.81 million, reached on February 1, 2006.
Performance
LFCR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$14.40 M
-$5.61 M-63.79%
November 24, 2024
Summary
- As of February 7, 2025, LFCR TTM free cash flow is -$14.40 million, with the most recent change of -$5.61 million (-63.79%) on November 24, 2024.
- Over the past year, LFCR TTM FCF has increased by +$19.18 million (+57.12%).
- LFCR TTM FCF is now -168.22% below its all-time high of $21.10 million, reached on February 1, 2013.
Performance
LFCR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
LFCR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.4% | -10.2% | +57.1% |
| 3 y3 years | -107.2% | -10.2% | +57.1% |
| 5 y5 years | +36.8% | +44.8% | +63.5% |
LFCR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -107.2% | +65.5% | -242.9% | +63.1% | -63.8% | +72.6% |
| 5 y | 5-year | -107.2% | +65.5% | -169.2% | +63.1% | -733.6% | +72.6% |
| alltime | all time | -207.9% | +65.5% | -162.1% | +63.1% | -168.2% | +72.6% |
Lifecore Biomedical Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | - | -$8.58 M(+112.6%) | -$14.40 M(+63.8%) |
| Aug 2024 | - | -$4.04 M(-167.2%) | -$8.79 M(-51.5%) |
| May 2024 | -$18.14 M(-53.4%) | $6.00 M(-177.1%) | -$18.14 M(-46.0%) |
| Feb 2024 | - | -$7.79 M(+161.9%) | -$33.58 M(-24.7%) |
| Nov 2023 | - | -$2.97 M(-77.8%) | -$44.62 M(-6.7%) |
| Aug 2023 | - | -$13.38 M(+41.8%) | -$47.84 M(+22.9%) |
| May 2023 | -$38.92 M(-25.9%) | -$9.44 M(-49.9%) | -$38.92 M(-6.1%) |
| Feb 2023 | - | -$18.82 M(+203.6%) | -$41.44 M(-9.7%) |
| Nov 2022 | - | -$6.20 M(+39.0%) | -$45.88 M(-8.1%) |
| Aug 2022 | - | -$4.46 M(-62.7%) | -$49.91 M(-5.0%) |
| May 2022 | -$52.53 M(+500.2%) | -$11.95 M(-48.6%) | -$52.53 M(+8.2%) |
| Feb 2022 | - | -$23.27 M(+127.4%) | -$48.55 M(+30.8%) |
| Nov 2021 | - | -$10.23 M(+44.5%) | -$37.12 M(+31.5%) |
| Aug 2021 | - | -$7.08 M(-11.1%) | -$28.23 M(+222.6%) |
| May 2021 | -$8.75 M(-80.0%) | - | - |
| May 2021 | - | -$7.97 M(-32.6%) | -$8.75 M(-51.5%) |
| Feb 2021 | - | -$11.83 M(+777.1%) | -$18.05 M(+945.4%) |
| Nov 2020 | - | -$1.35 M(-110.9%) | -$1.73 M(-89.1%) |
| Aug 2020 | - | $12.40 M(-171.8%) | -$15.91 M(-63.6%) |
| May 2020 | -$43.73 M(+52.3%) | -$17.27 M(-484.2%) | -$43.73 M(+10.8%) |
| Feb 2020 | - | $4.50 M(-128.9%) | -$39.48 M(-14.0%) |
| Nov 2019 | - | -$15.53 M(+0.7%) | -$45.88 M(+43.9%) |
| Aug 2019 | - | -$15.42 M(+18.4%) | -$31.88 M(+11.0%) |
| May 2019 | -$28.71 M(+107.9%) | -$13.02 M(+581.6%) | -$28.71 M(-1.2%) |
| Feb 2019 | - | -$1.91 M(+24.8%) | -$29.07 M(+18.7%) |
| Nov 2018 | - | -$1.53 M(-87.5%) | -$24.50 M(+3.0%) |
| Aug 2018 | - | -$12.25 M(-8.4%) | -$23.79 M(+72.2%) |
| May 2018 | -$13.81 M(-302.1%) | -$13.38 M(-601.7%) | -$13.81 M(+89.4%) |
| Feb 2018 | - | $2.67 M(-423.5%) | -$7.29 M(-347.6%) |
| Nov 2017 | - | -$824.00 K(-63.8%) | $2.94 M(+1226.6%) |
| Aug 2017 | - | -$2.28 M(-66.8%) | $222.00 K(-96.8%) |
| May 2017 | $6.83 M(-136.1%) | -$6.86 M(-153.1%) | $6.83 M(-52.8%) |
| Feb 2017 | - | $12.90 M(-463.8%) | $14.49 M(-377.4%) |
| Nov 2016 | - | -$3.55 M(-181.8%) | -$5.22 M(-44.1%) |
| Aug 2016 | - | $4.34 M(+444.7%) | -$9.35 M(-50.6%) |
| May 2016 | -$18.93 M(-307.9%) | $796.00 K(-111.7%) | -$18.93 M(+37.2%) |
| Feb 2016 | - | -$6.81 M(-11.2%) | -$13.80 M(>+9900.0%) |
| Nov 2015 | - | -$7.67 M(+46.0%) | -$29.00 K(-100.7%) |
| Aug 2015 | - | -$5.25 M(-188.5%) | $4.01 M(-56.0%) |
| May 2015 | $9.11 M(+47.9%) | $5.93 M(-14.7%) | $9.11 M(+60.0%) |
| Feb 2015 | - | $6.96 M(-291.7%) | $5.69 M(-1.2%) |
| Nov 2014 | - | -$3.63 M(+2241.9%) | $5.76 M(-0.8%) |
| Aug 2014 | - | -$155.00 K(-106.2%) | $5.81 M(-5.7%) |
| May 2014 | $6.16 M(-50.1%) | $2.52 M(-64.2%) | $6.16 M(-12.7%) |
| Feb 2014 | - | $7.03 M(-296.3%) | $7.06 M(-28.4%) |
| Nov 2013 | - | -$3.58 M(-1955.4%) | $9.86 M(+3.9%) |
| Aug 2013 | - | $193.00 K(-94.4%) | $9.49 M(-23.2%) |
| May 2013 | $12.35 M(-26.5%) | $3.42 M(-65.3%) | $12.35 M(-41.5%) |
| Feb 2013 | - | $9.83 M(-348.8%) | $21.10 M(+7.1%) |
| Nov 2012 | - | -$3.95 M(-229.3%) | $19.70 M(+15.4%) |
| Aug 2012 | - | $3.06 M(-74.9%) | $17.07 M(+1.5%) |
| May 2012 | $16.81 M(+115.9%) | $12.17 M(+44.4%) | $16.81 M(+245.2%) |
| Feb 2012 | - | $8.43 M(-228.1%) | $4.87 M(-9.5%) |
| Nov 2011 | - | -$6.58 M(-335.3%) | $5.38 M(-31.6%) |
| Aug 2011 | - | $2.80 M(+1137.6%) | $7.88 M(+1.2%) |
| May 2011 | $7.79 M | $226.00 K(-97.5%) | $7.79 M(+19.5%) |
| Feb 2011 | - | $8.94 M(-318.7%) | $6.51 M(-4753.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | -$4.09 M(-251.1%) | -$140.00 K(-106.8%) |
| Aug 2010 | - | $2.71 M(-359.3%) | $2.07 M(-9.8%) |
| May 2010 | $2.29 M(-52.9%) | -$1.04 M(-145.7%) | $2.29 M(-55.0%) |
| Feb 2010 | - | $2.29 M(-221.4%) | $5.09 M(+0.9%) |
| Nov 2009 | - | -$1.88 M(-164.2%) | $5.04 M(-22.6%) |
| Aug 2009 | - | $2.93 M(+67.4%) | $6.51 M(+34.0%) |
| May 2009 | $4.86 M(-63.4%) | $1.75 M(-21.8%) | $4.86 M(-33.5%) |
| Feb 2009 | - | $2.24 M(-646.1%) | $7.30 M(-32.6%) |
| Nov 2008 | - | -$410.00 K(-132.1%) | $10.83 M(+1.8%) |
| Aug 2008 | - | $1.28 M(-69.5%) | $10.64 M(-19.9%) |
| May 2008 | $13.28 M(-250.2%) | $4.20 M(-27.3%) | $13.28 M(-0.7%) |
| Feb 2008 | - | $5.77 M(-1053.7%) | $13.38 M(+120.1%) |
| Nov 2007 | - | -$605.00 K(-115.4%) | $6.08 M(-1026.4%) |
| Aug 2007 | - | $3.92 M(-8.7%) | -$656.00 K(-92.6%) |
| May 2007 | -$8.84 M(-244.5%) | $4.29 M(-380.5%) | -$8.84 M(-4.7%) |
| Feb 2007 | - | -$1.53 M(-79.1%) | -$9.28 M(-253.2%) |
| Nov 2006 | - | -$7.34 M(+71.9%) | $6.06 M(+28.2%) |
| Aug 2006 | - | -$4.27 M(-210.7%) | $4.72 M(-22.8%) |
| May 2006 | $6.12 M(-34.8%) | $3.85 M(-72.1%) | $6.12 M(+132.9%) |
| Feb 2006 | - | $13.81 M(-259.3%) | $2.63 M(+68.7%) |
| Nov 2005 | - | -$8.67 M(+201.7%) | $1.56 M(-80.8%) |
| Aug 2005 | - | -$2.87 M(-893.9%) | $8.12 M(-13.5%) |
| May 2005 | $9.39 M(+128.0%) | $362.00 K(-97.2%) | $9.39 M(+1.6%) |
| Feb 2005 | - | $12.74 M(-704.0%) | $9.24 M(+33.0%) |
| Nov 2004 | - | -$2.11 M(+31.6%) | $6.95 M(+265.4%) |
| Aug 2004 | - | -$1.60 M(-838.2%) | $1.90 M(-53.8%) |
| May 2004 | $4.12 M(+356.0%) | $217.00 K(-97.9%) | $4.12 M(+3.8%) |
| Feb 2004 | - | $10.44 M(-245.9%) | $3.97 M(-163.1%) |
| Nov 2003 | - | -$7.16 M(-1265.6%) | -$6.28 M(+102.8%) |
| Aug 2003 | - | $614.00 K(+830.3%) | -$3.10 M(-49.7%) |
| May 2003 | $903.00 K(-134.1%) | - | - |
| Apr 2003 | - | $66.00 K(-66.2%) | -$6.16 M(-36.9%) |
| Jan 2003 | - | $195.00 K(-104.9%) | -$9.76 M(+268.8%) |
| Oct 2002 | -$2.65 M(-81.8%) | -$3.97 M(+62.3%) | -$2.65 M(+389.3%) |
| Jul 2002 | - | -$2.45 M(-30.8%) | -$541.00 K(+405.6%) |
| Apr 2002 | - | -$3.54 M(-148.4%) | -$107.00 K(-78.1%) |
| Jan 2002 | - | $7.31 M(-491.7%) | -$488.00 K(-96.6%) |
| Oct 2001 | -$14.53 M(-2899.6%) | -$1.87 M(-7.3%) | -$14.53 M(+36.2%) |
| Jul 2001 | - | -$2.01 M(-48.6%) | -$10.67 M(+18.5%) |
| Apr 2001 | - | -$3.92 M(-41.8%) | -$9.00 M(+1654.0%) |
| Jan 2001 | - | -$6.73 M(-437.1%) | -$513.00 K(-198.8%) |
| Oct 2000 | $519.00 K(-111.1%) | $2.00 M(-678.8%) | $519.00 K(+19.3%) |
| Jul 2000 | - | -$345.00 K(-107.6%) | $435.00 K(-116.0%) |
| Apr 2000 | - | $4.57 M(-180.1%) | -$2.72 M(-68.7%) |
| Jan 2000 | - | -$5.70 M(-398.0%) | -$8.69 M(+85.3%) |
| Oct 1999 | -$4.69 M(-40.7%) | $1.91 M(-154.7%) | -$4.69 M(-43.5%) |
| Jul 1999 | - | -$3.50 M(+150.0%) | -$8.30 M(-11.7%) |
| Apr 1999 | - | -$1.40 M(-17.6%) | -$9.40 M(-10.5%) |
| Jan 1999 | - | -$1.70 M(0.0%) | -$10.50 M(+32.9%) |
| Oct 1998 | -$7.90 M(+16.2%) | -$1.70 M(-63.0%) | -$7.90 M(-2.5%) |
| Jul 1998 | - | -$4.60 M(+84.0%) | -$8.10 M(+58.8%) |
| Apr 1998 | - | -$2.50 M(-377.8%) | -$5.10 M(+21.4%) |
| Jan 1998 | - | $900.00 K(-147.4%) | -$4.20 M(-38.2%) |
| Oct 1997 | -$6.80 M(+70.0%) | -$1.90 M(+18.8%) | -$6.80 M(+38.8%) |
| Jul 1997 | - | -$1.60 M(0.0%) | -$4.90 M(+48.5%) |
| Apr 1997 | - | -$1.60 M(-5.9%) | -$3.30 M(+94.1%) |
| Jan 1997 | - | -$1.70 M | -$1.70 M |
| Oct 1996 | -$4.00 M | - | - |
FAQ
- What is Lifecore Biomedical annual free cash flow?
- What is the all time high annual FCF for Lifecore Biomedical?
- What is Lifecore Biomedical annual FCF year-on-year change?
- What is Lifecore Biomedical quarterly free cash flow?
- What is the all time high quarterly FCF for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly FCF year-on-year change?
- What is Lifecore Biomedical TTM free cash flow?
- What is the all time high TTM FCF for Lifecore Biomedical?
- What is Lifecore Biomedical TTM FCF year-on-year change?
What is Lifecore Biomedical annual free cash flow?
The current annual FCF of LFCR is -$18.14 M
What is the all time high annual FCF for Lifecore Biomedical?
Lifecore Biomedical all-time high annual free cash flow is $16.81 M
What is Lifecore Biomedical annual FCF year-on-year change?
Over the past year, LFCR annual free cash flow has changed by +$20.79 M (+53.40%)
What is Lifecore Biomedical quarterly free cash flow?
The current quarterly FCF of LFCR is -$8.58 M
What is the all time high quarterly FCF for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly free cash flow is $13.81 M
What is Lifecore Biomedical quarterly FCF year-on-year change?
Over the past year, LFCR quarterly free cash flow has changed by -$795.00 K (-10.21%)
What is Lifecore Biomedical TTM free cash flow?
The current TTM FCF of LFCR is -$14.40 M
What is the all time high TTM FCF for Lifecore Biomedical?
Lifecore Biomedical all-time high TTM free cash flow is $21.10 M
What is Lifecore Biomedical TTM FCF year-on-year change?
Over the past year, LFCR TTM free cash flow has changed by +$19.18 M (+57.12%)